NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Reverb Therapeutics

Reverb Therapeutics

Private
VancouverHealthcare & Life Scienceshttps://www.reverbtx.com/en/

Last Round

VC Round

Mar 19, 2026

Total Funding Raised

$24M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Reverb Therapeutics is a biotechnology company that develops bispecific antibodies designed to redirect the body's own cytokines to treat cancer and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

small molecule therapeuticsdrug discoverybiotechnologypreclinical developmentbispecific antibodybiotechquantitative systems pharmacologyQSPAI-guided drug discoverycomputational biologydrug pipelinein silico drug designtherapeutic developmentpharma partneringearly-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Reverb Therapeutics Comparables

Compare Reverb Therapeutics with similar companies based on industry and business-model similarity.

Reverb Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Reverb Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 19, 2026
SeedFeb 19, 2025
SeedNov 15, 2023

Key People

Founding team and executive leadership

David de Graaf

Co-Founder, CEO & President

Founding Team

Reverb Therapeutics Investors

Notable investors and investment history

Reverb Therapeutics investors
InvestorRounds
InBC Investment Corp.Seed, VC Round
Finchley Healthcare VenturesSeed
Amplitude VenturesSeed, VC Round
Seido CapitalSeed, VC Round
KdT VenturesSeed, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors grew 599% MoM, from 394 to 2.8K.

  • Apr 25, 2026

    Grew 16% QoQ, from 19 to 22 employees.

Reverb Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Reverb Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Reverb Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersVancouver
Employee Range21
Year Founded2022
Last FundingMar 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.